We target funds focused on providing later stage capital to high-potential, UK innovative life sciences companies 🔬 #LSIP

Find out more about Life Sciences Investment Programme here 👉 bit.ly/3NgpNTV

There are now over 1,190 innovative, high-growth companies in our underlying portfolio.

Download our Annual Report & Accounts: bit.ly/3ih8q8c

#BPCAnnualReport2023

ICYMI: Reflecting on the findings of British Business Bank's #SBFM2024 report, our MD Christine Hockley highlights opportunities of backing ground-breaking R&D companies and recents investments of our #FutureFundBreakthrough programme.

➡️ bit.ly/435CpmM

As the UK’s largest domestic investor in UK venture and venture growth opportunities, we are increasing access to, and the availability of, long-term, patient finance.

We do this via three schemes, each one addressing specific market issues ⤵️
bit.ly/46AnNw8

We target funds focused on providing later stage capital to high-potential, UK innovative life sciences companies 🔬 #LSIP

Find out more about Life Sciences Investment Programme here 👉 bit.ly/3NgpNTV

#ICYMI : New features of Future Fund: Breakthrough will make it easier to fuel innovation.

Minimum round size is now £20m and there’ll be more flexibility for sponsor investors.

👉 bit.ly/3Tyb1t9

.@Quantexa is a decision intelligence company using #AI and network analytics to uncover hidden customer connections and behaviours.

The company is now valued at more than £1 billion and is our second unicorn in our direct investment portfolio 🦄

Following a decline in tech funding over 2023 in Europe, our Managing Director for Direct and Co-Investments Ian Connatty sat down with UKTN to discuss funding over a full economic cycle and highlight existing opportunities for investors 👇 uktech.news/news/investmen…

🤝 We’re proud to have supported 17 of the startups on this year’s #Sifted100 leaderboard, which ranks the fastest growing startups across the UK and Ireland. Sifted

As the UK’s largest domestic investor in UK venture and venture growth opportunities, we are increasing access to, and the availability of, long-term, patient finance.

We do this via three schemes, each one addressing specific market issues ⤵️
lnkd.in/ebe_NYwQ

#ICYMI : New features of Future Fund: Breakthrough will make it easier to fuel innovation.

Minimum round size is now £20m and there’ll be more flexibility for sponsor investors.

👉 bit.ly/3Tyb1t9

Following a decline in tech funding over 2023 in Europe, our Managing Director for Direct and Co-Investments Ian Connatty sat down with UKTN to discuss funding over a full economic cycle and highlight existing opportunities for investors 👇 uktech.news/news/investmen…

.British Business Bank CEO Louis Taylor highlights the impact of our Future Fund: Breakthrough.

Read more here: bit.ly/3TQmDsN

We look forward to collaborating with the Invest in Women Taskforce to unlock the full potential of the UK’s female entrepreneurs.

Read our MD, Funds, Christine Hockley's full response to the Government's announcement at #BusinessConnect 👉 bit.ly/4ctWrvu

As the UK’s largest domestic investor in UK venture and venture growth opportunities, we are increasing access to, and the availability of, long-term, patient finance.

We do this via three schemes, each one addressing specific market issues ⤵️
lnkd.in/ebe_NYwQ

Our MD Christine Hockley spoke on BBC Woman's Hour about funding options and support available for female entrepreneurs.